Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_assertion type Assertion NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_head.
- NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_assertion description "[In both normal and malignant prostate tissues, FOXP3 is both necessary and sufficient to transcriptionally repress cMYC, the most commonly overexpressed oncogene in prostate cancer as well as among the aggregates of other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_provenance.
- NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_assertion evidence source_evidence_literature NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_provenance.
- NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_assertion SIO_000772 19800578 NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_provenance.
- NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_assertion wasDerivedFrom befree-20140225 NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_provenance.
- NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_assertion wasGeneratedBy ECO_0000203 NP295616.RAytIkliqYSakA22VsB5FqlruF4P78OGaU8lyOWphRBas130_provenance.